Many people who have taken Ozempic for weight loss are now taking legal action against the popular GLP-1 drug’s manufacturer.…
Read More →
When a serious injury disrupts someone’s ability to work and earn money, the ripple effects are immediate and far-reaching. Questions…
Read More →
When doctors prescribe medication for us, we expect it to help in some way. We might hope that it will…
Read More →
As more patients come forward with questions about the potential link between dupilumab (Dupixent®) and certain types of cancer, it’s…
Read More →
On Friday, October 3, 2025, the United States Supreme Court announced that it will provide vital guidance regarding the extent…
Read More →
US public companies increasingly embrace digital assets as part of their corporate treasury strategies. Known as digital asset treasury (DAT)…
Read More →
In the last decade, various large cities including New York City, Philadelphia, Chicago, Seattle, San Francisco, Emeryville, and Los Angeles…
Read More →
Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health…
Read More →
Our Investment Funds and Securities Litigation teams explain how the Securities and Exchange Commission (SEC) has clarified the treatment of…
Read More →
On September 15, 2025, the Office of the Director of National Intelligence (“DNI”) published the first exclusion and removal order (“Order”) under…
Read More →